Title | Hearings, Meetings, Proceedings, etc.: Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection |
ToC Doc | Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection |
Docket Number | 2024-12532 |
Type | Notice |
Subject | Hearings, Meetings, Proceedings, etc.: Oncologic Drugs Advisory Committee, Supplemental Biologics License Application 761069/S-043 for Imfinzi (durvalumab) Injection |
Publication Date | 2024-06-07 |
Last Updated Date | 2024-06-06 08:21:29 -0400 |
Last Public Inspection | 2024-06-06 |
Filed At | 2024-06-06T08:45:00.000-04:00 |
2024-12532_PI.pdf (111732 bytes) | |
Download | TXT / HTML / JSON |
Number of Pages | 6 |
Filing Type | regular |
Agencies | Food and Drug Administration |
You can find the raw source document below...